| II-14 Mattia Berton Physiologically based pharmacokinetic modelling to investigate the impact of obesity on the pharmacokinetics of rilpivirine, efavirenz, and etravirine Wednesday 15:35-17:00 |
| II-14 Mattia Berton Physiologically based pharmacokinetic modelling to investigate the impact of obesity on the pharmacokinetics of rilpivirine, efavirenz, and etravirine Wednesday 15:35-17:00 |